Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTAreportSummer2022web
2018_Summer_CMTA_Report
CMTAreportSummer2022web
2018_Summer_CMTA_Report
Actio Biosciences Doses First Participant in Phase I Clinical Trial | Future Phase Ib Clinical Trial to Focus on CMT2C
…as they move this program forward for people living with CMT2C. Get Involved in CMT Research Not yet registered with Patients as Partners in Research? By registering, you’ll be among…
CMT Awareness Month 2023
…color print. Check out the Sky of Fame. Register for the 2023 Patient & Research Summit The 2023 CMTA Patient & Research Summit on Saturday, November 4th will offer life-improving…
CMTA Announces Strategic Partnership with Acceleron to Advance CMT Treatment Options
…developing medicines to treat serious and rare diseases, including CMT. The CMTA’s Strategy to Accelerate Research (STAR) connects top CMT clinicians and academic researchers with pharmaceutical partners committed to developing…
CMTA and ToolGen Announce CMT1A Collaboration
…CMTA has been able to establish research partnerships with almost 40 pharmaceutical and biotech companies, and leading research labs around the world.” The testing alliance with ToolGen involves access to…
Diana Bharucha-Goebel, MD Joins the CMTA-STAR Advisory Board
In a suite of exciting appointments, the Charcot-Marie-Tooth Association (CMTA) Strategy to Accelerate Research (STAR) Advisory Board is delighted to announce the appointment of Dr. Diana Bharucha-Goebel to their Clinical…
CMTA Adds Drug Development Expert Martine Garnier to STAR Advisory Board
…disease. It does so with an aggressive, multipronged attack, bringing together a group of top-flight researchers and experts and directly funding their work. CMTA launched its Strategy to Accelerate Research,…